Immuneering Corp. (IMRX)
4.95
+0.02
(+0.41%)
USD |
NASDAQ |
Feb 09, 16:00
4.95
0.00 (0.00%)
After-Hours: 07:40
Immuneering EPS Diluted (Quarterly) : -0.3772 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| Verastem, Inc. | -1.347 |
| Fortress Biotech, Inc. | 0.111 |
| Phathom Pharmaceuticals, Inc. | -0.4084 |
| Absci Corp. | -0.1997 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.96M |
| Total Expenses (Quarterly) | 14.96M |
| Enterprise Value | 95.97M |
| Earnings Yield | -36.02% |
| Normalized Earnings Yield | -36.02 |